GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwangdong Healthbio Co Ltd (XKRX:086220) » Definitions » Research & Development

Kwangdong Healthbio Co (XKRX:086220) Research & Development : ₩0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Kwangdong Healthbio Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Kwangdong Healthbio Co's Research & Development for the six months ended in Dec. 2024 was ₩0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.

Kwangdong Healthbio Co Research & Development Historical Data

The historical data trend for Kwangdong Healthbio Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwangdong Healthbio Co Research & Development Chart

Kwangdong Healthbio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kwangdong Healthbio Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Kwangdong Healthbio Co Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kwangdong Healthbio Co  (XKRX:086220) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kwangdong Healthbio Co Research & Development Related Terms

Thank you for viewing the detailed overview of Kwangdong Healthbio Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Kwangdong Healthbio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwangdong Healthbio Co Ltd (XKRX:086220) » Definitions » Research & Development
Comparable Companies
XKRX:900300 XKRX:233990 XKRX:250030 XKRX:101390 XKRX:317860 XKRX:266870 XKRX:014100 XKRX:317240 XKRX:252500 XKRX:025620 PG XPAR:OR LSE:ULVR CL BOM:500696 KMB KVUE LSE:RKT XTER:HEN3 XTER:BEI
Traded in Other Exchanges
N/A
Address
39 Yangcheong Songdae-gil, Ochang-eup, Cheongwon-gu, Chungcheongbuk-do, Songdae-ri, Cheongju-si, KOR
Website
http://www.kdhealthbio.com
Kwangdong Healthbio Co Ltd formerly BL Healthcare Corp is a Bio-venture company, which develops, manufactures, and sells health functional food and pharmaceutical products. The Company's products include weight-loss pills, vitamins, and other nutrition supplements. It also produces personal care items such as cosmetics, hair care products, and skincare products.

Kwangdong Healthbio Co Headlines

No Headlines